Navigation Links
BioDelivery Sciences Announces Completion of Recruitment in BEMA Buprenorphine Phase 3 Chronic Pain Study
Date:4/5/2011

RALEIGH, N.C., April 5, 2011 /PRNewswire/ -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced today completion of enrollment in its Phase 3 clinical trial assessing the efficacy and safety of BEMA Buprenorphine for the treatment of moderate to severe chronic pain.

(Logo: https://photos.prnewswire.com/prnh/20110217/CL49801LOGO)

"The completion of enrollment in our Phase 3 efficacy study marks another very important milestone in our clinical development program for BEMA Buprenorphine in the management of chronic pain," stated Dr. Andrew Finn, Executive Vice President of Product Development at BDSI.  "We are very pleased to have achieved our aggressive recruitment and enrollment goals.  This milestone keeps us on target for reporting top-line study results in the third quarter of this year and is consistent with a timeline that would allow for a New Drug Application (NDA) to be filed in the second quarter of 2012."

BDSI believes that there remains a significant unmet medical need for potent new analgesics for the treatment of chronic pain.  The company believes that buprenorphine is an attractive option for development because of its potent analgesic properties, its differentiating characteristics from other opioids and its DEA Schedule III designation, which means there is less addiction potential than Schedule II products.  In addition, BEMA Buprenorphine has the potential to be the first oral transmucosal form of buprenorphine to treat chronic pain in the U.S.  According to Wolters Kluwer, opioid analgesic sales in the U.S. are in excess of $10 billion and growing, and BDSI believes that BEMA Buprenorphine has the potential to exceed $500 million in peak annual sales.

Additional Information on Phase 3 Study Design (BUP-301)

This Phase 3 trial of BEMA Buprenorphine (referred to as BUP-301) is
'/>"/>

SOURCE BioDelivery Sciences International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioDelivery Sciences to Present at the 23rd Annual ROTH OC Growth Stock Conference
2. BioDelivery Sciences Confirms 505(b)(2) Pathway for BEMA Buprenorphine/Naloxone for Opioid Dependence Following FDA Meeting
3. BioDelivery Sciences Announces BEMA Buprenorphine Phase 3 Chronic Pain Study More Than 50% Recruited and on Schedule
4. MonoSol Rx, LLC Files Patent Infringement and False Marking Lawsuit Against BioDelivery Sciences International, Inc., MEDA Pharmaceuticals Inc., and Aveva Drug Delivery Systems, Inc.
5. TCG Lifesciences Expands Pharmaceutical, Biotechnology Research Initiatives with CAS SciFinder®
6. Sofie Biosciences Launches a High Performance, Benchtop Preclinical PET System Using New Generation Detector Technology
7. Caliper Life Sciences Launches Novel COX-2 Probe to Enable Personalized Medicine Research
8. Regado Biosciences, Inc. Presents Results of the RADAR Phase 2b Clinical Trial of its REG1 Anticoagulation System
9. Neurocrine Biosciences to Present at the 10th Annual Needham Healthcare Conference
10. Regado Biosciences to Present at the Needham & Companys 10th Annual Healthcare Conference in New York City
11. Newborn Possibilities Fund Awards Grant to Georgia Health Sciences University Foundation to Support Groundbreaking Pediatric Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market ... is an autoimmune disease that permanently destroys beta cells of ... longer produce insulin. Over the last 90 years, insulin therapy ... can be offered to a patient who is newly diagnosed ... of action - long-acting as well as short or rapid-acting ...
(Date:5/27/2015)... 27, 2015 PharmaPoint: Systemic Lupus Erythematosus and ... to 2022 - Event-Driven Update Summary ... GlaxoSmithKline,s Benlysta is the only drug that has gained ... Following Benlysta,s launch, patients, uptake has remained low, but ... to grow the lupus market in terms of value ...
(Date:5/27/2015)... , May 27, 2015 ... http://www.researchandmarkets.com/research/bnrjw5/2015_strategies ) has announced the addition of ... Acid Testing Market"  report to their ... , ,Major issues pertaining to the US ... economic, regulatory, demographic, social and technological trends ...
Breaking Medicine Technology:PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 2PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 3PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 4PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update 2PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update 3United States Nucleic Acid Testing Market Strategies 2015-2020 2
(Date:5/27/2015)... (PRWEB) May 28, 2015 Throughout the past ... site for research comparing the validity and reliability of the ... Preeti Nair, P.T., Ph.D., Associate Professor in the Department of ... for the study. , The Shaw Gait Assessment is a ... of equipment. The GaitRite is considered the gold standard ...
(Date:5/27/2015)... StatRad, a leading provider of cloud-based ... introduce Mr. Chris E. Hafey as its new Chief ... record of leading new development projects and has extensive ... recently served as the Chief Technology Officer for OnPoint ... Architect for Vital Images. , "I am very excited ...
(Date:5/27/2015)... Khanna Vision Institute (KVI) announced the launch ... on keratoconus eye disease . Keratoconus is commonly known ... onset in the teenage years. It worsens over the next ... clear part of the eye is defective. It becomes thin ... results in poor vision which cannot even be corrected with ...
(Date:5/27/2015)... Arizona (PRWEB) May 27, 2015 Continuing ... mission of healthier patients in the community, SmartPractice® ... Center (formerly John C. Lincoln). SmartPractice Vice President of ... Michelle Shaw presented a $25,000 check to Paulla Miller, ... HonorHealth’s Breast Health & Research Center on April 30. ...
(Date:5/27/2015)... CT (PRWEB) May 27, 2015 Dr. ... Institute based in Stamford, CT has been selected as ... the first physicians nationwide (and the only physician in ... injectable which allows for the removal of submental fat ... to no recovery time, no surgery and minimal risks. ...
Breaking Medicine News(10 mins):Health News:Push to Walk Partners with Seton Hall University for Study 2Health News:StatRad Introduces Mr. Chris E. Hafey as Chief Technology Officer, and the Release of its Advanced Pure HTML5 DICOM Image Uploader 2Health News:KVI announced the launch of The Keratoconus website focused on age based keratoconus treatment . 2Health News:SmartPractice Donates $25,000 to HonorHealth Breast Health and Research Center 2Health News:Connecticut Skin Institute First in Connecticut to Offer New Surgery-Free “Double Chin” Fat Reduction Treatment 2Health News:Connecticut Skin Institute First in Connecticut to Offer New Surgery-Free “Double Chin” Fat Reduction Treatment 3
... network of collaborative research. Building on a tool that was ... of Brain , Dr. Yaniv Assaf of Tel Aviv ... of scientists to understand how different parts of the human ... "brain atlas." Brain researchers already know that autism and ...
... as young as four weeks old are being fed a ... new Australian research. A study published in the journal ... been introduced to high fat, salt and sugar foods, despite ... Researcher Jane Scott and colleagues tracked 587 women ...
... Gardner HealthDay Reporter , MONDAY, Sept. 6 ... and proteins from vegetable sources rather than meats is ... types of diets over two decades, researchers found that ... death from cardiovascular disease and cancer, and a lower ...
... About 17 percent of all visits to hospital emergency ... retail medical clinics or urgent care centers, potentially saving ... a new RAND Corporation study. Conditions that could ... fractures and lacerations, according to findings published in the ...
... of California, San Diego School of Medicine have shown ... examining dynamic geometric patterns than they do looking at ... either typical or developmentally delayed toddlers. The results ... patterns early in life may be a signature behavior ...
... a combination of medication and a psychosocial intervention appear ... improved insight, quality of life and social functioningthan those ... September issue of Archives of General Psychiatry , ... the mainstay of therapy for patients with schizophrenia, but ...
Cached Medicine News:Health News:Mapping a brain atlas 2Health News:What are babies made of? Research shows for some it is sugar, salt and not all things nice 2Health News:Low-Carb Diets Heavy on Meat May Raise Health Risks 2Health News:Many hospital emergency department visits could be treated elsewhere, study finds 2Health News:Many hospital emergency department visits could be treated elsewhere, study finds 3Health News:Visual pattern preference may be indicator of autism in toddlers 2Health News:Visual pattern preference may be indicator of autism in toddlers 3Health News:Combining medication and psychosocial treatments may benefit patients with early-stage schizophrenia 2
... Experience the finest surgical-quality loupes ... set the standard for innovative optical ... support. Delivering optimum performance with maximum ... choice for medical professionals worldwide. Make ...
... the finest surgical-quality loupes available ... standard for innovative optical design, combining ... optimum performance with maximum comfort, SheerVision ... medical professionals worldwide. Make both a ...
... SheerVision manufactures its signature line of award-winning ... Frame. These next generation loupes feature ... design, and are multi-coated lens for anti-glare, ... SV Sport frame offers a stylish, yet ...
... FireFly LED light offers superior illumination in ... FireFly LED you'll get powerful, long-lasting illumination ... practice demands. High center-beam brightness and hands-free ... while the rechargeable battery provides over five ...
Medicine Products: